{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T11:06:27Z","timestamp":1788606387949,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,3,15]],"date-time":"2014-03-15T00:00:00Z","timestamp":1394841600000},"content-version":"vor","delay-in-days":379,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"T32","award":["AI007536-11"],"award-info":[{"award-number":["AI007536-11"]}]},{"name":"T32","award":["AI007536-12"],"award-info":[{"award-number":["AI007536-12"]}]},{"name":"Sealy Center for Vaccine Development and T32","award":["AI7526-11"],"award-info":[{"award-number":["AI7526-11"]}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Disease (NIAID)","doi-asserted-by":"crossref","award":["U54AIO57156"],"award-info":[{"award-number":["U54AIO57156"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.virol.2012.11.013","type":"journal-article","created":{"date-parts":[[2013,1,22]],"date-time":"2013-01-22T17:05:11Z","timestamp":1358874311000},"page":"81-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice"],"prefix":"10.1016","volume":"437","author":[{"given":"Shannan L.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Guerbois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodion","family":"Gorchakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth S.","family":"Plante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi L.","family":"Forrester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott C.","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2012.11.013_bib1","doi-asserted-by":"crossref","first-page":"e1875","DOI":"10.1371\/journal.pntd.0001875","article-title":"Venezuelan equine encephalitis virus activity in the Gulf coast region of Mexico, 2003\u20132010","volume":"6","author":"Adams","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virol.2012.11.013_bib2","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1128\/JVI.76.4.1718-1730.2002","article-title":"Positively charged amino acid substitutions in the e2 envelope glycoprotein are associated with the emergence of venezuelan equine encephalitis virus","volume":"76","author":"Brault","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.11.013_bib3","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1128\/JVI.02545-09","article-title":"T cells facilitate recovery from Venezuelan equine encephalitis virus-induced encephalomyelitis in the absence of antibody","volume":"84","author":"Brooke","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.11.013_bib4","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1093\/infdis\/136.3.354","article-title":"Persistence in humans of antibody to subtypes of Venezuelan equine encephalomyelitis (Vee) virus after immunization with attenuated (Tc-83) vee virus-vaccine","volume":"136","author":"Burke","year":"1977","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.11.013_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1006\/viro.1995.1458","article-title":"Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1","volume":"212","author":"Davis","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.11.013_bib6","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.3201\/eid1012.040393","article-title":"Venezuelan equine encephalitis virus, southern Mexico","volume":"10","author":"Estrada-Franco","year":"2004","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2012.11.013_bib7","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1128\/jcm.10.4.544-549.1979","article-title":"Neutralizing antibody-responses of humans and mice to vaccination with Venezuelan encephalitis (Tc-83) Virus","volume":"10","author":"Fillis","year":"1979","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virol.2012.11.013_bib8","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.vaccine.2006.10.030","article-title":"Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses","volume":"25","author":"Fine","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.11.013_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0168-1656(99)00131-5","article-title":"The use of bi-cistronic transfer vectors for the baculovirus expression system","volume":"75","author":"Finkelstein","year":"1999","journal-title":"J. Biotechnol."},{"key":"10.1016\/j.virol.2012.11.013_bib10","doi-asserted-by":"crossref","first-page":"11371","DOI":"10.1073\/pnas.93.21.11371","article-title":"Alphavirus-based expression vectors: strategies and applications","volume":"93","author":"Frolov","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2012.11.013_bib11","first-page":"238","article-title":"A study of equine virulence of naturally occurring Venezuelan encephalitis virus in Veracruz with description of antibody responses","volume":"65","author":"Garman","year":"1968","journal-title":"Bol. Oficina Sanit. Panam."},{"key":"10.1016\/j.virol.2012.11.013_bib12","first-page":"161","article-title":"Equine amplification and virulence of subtype IE Venezuelan equine encephalitis viruses isolated during the 1993 and 1996 Mexican epizootics","volume":"9","author":"Gonzalez-Salazar","year":"2003","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2012.11.013_bib13","doi-asserted-by":"crossref","first-page":"9128","DOI":"10.1128\/JVI.79.14.9128-9133.2005","article-title":"Envelope glycoprotein mutations mediate equine amplification and virulence of epizootic Venezuelan equine encephalitis virus","volume":"79","author":"Greene","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.11.013_bib14","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1016\/S0264-410X(00)00042-6","article-title":"Improved mucosal protection against Venezuelan equine encephalitis virus is induced by the molecularly defined, live-attenuated V3526 vaccine candidate","volume":"18","author":"Hart","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.11.013_bib15","doi-asserted-by":"crossref","first-page":"e1606","DOI":"10.1371\/journal.pntd.0001606","article-title":"Genetic and anatomic determinants of enzootic Venezuelan equine encephalitis virus infection of Culex (Melanoconion) taeniopus","volume":"6","author":"Kenney","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.virol.2012.11.013_bib16","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1016\/j.vaccine.2011.01.055","article-title":"Stability of RNA virus attenuation approaches","volume":"29","author":"Kenney","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.11.013_bib17","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1128\/jvi.67.3.1269-1277.1993","article-title":"Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5\u2019-noncoding region and the E2 envelope glycoprotein","volume":"67","author":"Kinney","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.11.013_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0042-6822(89)90347-4","article-title":"The full-length nucleotide-sequences of the virulent trinidad donkey strain of Venezuelan equine encephalitis-virus and its attenuated vaccine derivative, strain Tc-83","volume":"170","author":"Kinney","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.11.013_bib19","doi-asserted-by":"crossref","first-page":"49","DOI":"10.4269\/ajtmh.2001.64.49","article-title":"Comparative neurovirulence of attenuated and non-attenuated strains of Venezuelan equine encephalitis virus in mice","volume":"64","author":"Ludwig","year":"2001","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2012.11.013_bib20","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4269\/ajtmh.1998.59.100","article-title":"Association of Venezuelan equine encephalitis virus subtype IE with two equine epizootics in Mexico","volume":"59","author":"Oberste","year":"1998","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2012.11.013_bib21","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4269\/ajtmh.1999.60.630","article-title":"Geographic distribution of Venezuelan equine encephalitis virus subtype IE genotypes in Central America and Mexico","volume":"60","author":"Oberste","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2012.11.013_bib22","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1128\/JVI.80.6.2784-2796.2006","article-title":"Replication and clearance of Venezuelan equine encephalitis virus from the brains of animals vaccinated with chimeric SIN\/VEE viruses","volume":"80","author":"Paessler","year":"2006","journal-title":"J. Virol."},{"issue":"Suppl. 4","key":"10.1016\/j.virol.2012.11.013_bib23","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2009.07.095","article-title":"Vaccines for Venezuelan equine encephalitis","volume":"27","author":"Paessler","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.11.013_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.virol.2007.05.041","article-title":"Alpha-beta T cells provide protection against lethal encephalitis in the murine model of VEEV infection","volume":"367","author":"Paessler","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.11.013_bib25","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.vaccine.2011.12.121","article-title":"A vaccine candidate for eastern equine encephalitis virus based on IRES-mediated attenuation","volume":"30","author":"Pandya","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.11.013_bib26","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/oxfordjournals.aje.a121416","article-title":"Isolation of vaccine strain of Venezuelan equine encephalomyelitis virus from mosquitos in Louisiana","volume":"95","author":"Pedersen","year":"1972","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2012.11.013_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0264-410X(95)00168-Z","article-title":"Long-term duration of detectable neutralizing antibodies after administration of live-attenuated VEE vaccine and following booster vaccination with inactivated VEE vaccine","volume":"14","author":"Pittman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.11.013_bib28","doi-asserted-by":"crossref","first-page":"e1002142","DOI":"10.1371\/journal.ppat.1002142","article-title":"Novel Chikungunya vaccine candidate with an IRES-Based attenuation and host range alteration mechanism","volume":"7","author":"Plante","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2012.11.013_bib29","doi-asserted-by":"crossref","first-page":"4258","DOI":"10.1128\/JVI.74.9.4258-4263.2000","article-title":"The use of chimeric Venezuelan equine encephalitis viruses as an approach for the molecular identification of natural virulence determinants","volume":"74","author":"Powers","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2012.11.013_bib30","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/S0264-410X(03)00328-1","article-title":"Genetically engineered, live attenuated vaccines for Venezuelan equine encephalitis: testing in animal models","volume":"21","author":"Pratt","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.11.013_bib31","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1016\/j.vaccine.2004.12.023","article-title":"Genetically engineered, live, attenuated vaccines protect nonhuman primates against aerosol challenge with a virulent IE strain of Venezuelan equine encephalitis virus","volume":"23","author":"Reed","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2012.11.013_bib32","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/030098589803500508","article-title":"Comparative neurovirulence and tissue tropism of wild-type and attenuated strains of Venezuelan equine encephalitis virus administered by aerosol in C3H\/HeN and BALB\/c mice","volume":"35","author":"Steele","year":"1998","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.virol.2012.11.013_bib33","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4269\/ajtmh.1999.60.1041","article-title":"Limited potential for mosquito transmission of genetically engineered, live-attenuated Venezuelan equine encephalitis virus vaccine candidates","volume":"60","author":"Turell","year":"1999","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.virol.2012.11.013_bib34","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.virol.2008.04.020","article-title":"IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells","volume":"377","author":"Volkova","year":"2008","journal-title":"Virology"},{"key":"10.1016\/j.virol.2012.11.013_bib35","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/infdis\/128.3.271","article-title":"Experimental infection of horses with enzootic and epizootic strains of Venezuelan equine encephalomyelitis virus","volume":"128","author":"Walton","year":"1973","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2012.11.013_bib36","doi-asserted-by":"crossref","first-page":"10244","DOI":"10.1128\/JVI.75.21.10244-10249.2001","article-title":"The 5 \u2018 untranslated region of Rhopalosiphum padi virus contains an internal ribosome entry site which functions efficiently in mammalian, plant, and insect translation systems","volume":"75","author":"Woolaway","year":"2001","journal-title":"J. Vir."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212005739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682212005739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:19:15Z","timestamp":1758586755000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682212005739"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S0042682212005739"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2012.11.013","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IRES-based Venezuelan equine encephalitis vaccine candidate elicits protective immunity in mice","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2012.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}